Search

Your search keyword '"Chen, Liqun"' showing total 40 results

Search Constraints

Start Over You searched for: Author "Chen, Liqun" Remove constraint Author: "Chen, Liqun" Publisher american association for cancer research (aacr) Remove constraint Publisher: american association for cancer research (aacr)
40 results on '"Chen, Liqun"'

Search Results

1. Supplemental Figure 1 from A Four-Factor Immunoscore System That Predicts Clinical Outcome for Stage II/III Gastric Cancer

2. Supplemental Figure 1 from A Four-Factor Immunoscore System That Predicts Clinical Outcome for Stage II/III Gastric Cancer

3. Data from A Four-Factor Immunoscore System That Predicts Clinical Outcome for Stage II/III Gastric Cancer

4. Supplementary Data for publication from A Four-Factor Immunoscore System That Predicts Clinical Outcome for Stage II/III Gastric Cancer

5. Supplemental Figure 2 from A Four-Factor Immunoscore System That Predicts Clinical Outcome for Stage II/III Gastric Cancer

6. Supplemental Figure 2 from A Four-Factor Immunoscore System That Predicts Clinical Outcome for Stage II/III Gastric Cancer

7. Supplementary Data for publication from A Four-Factor Immunoscore System That Predicts Clinical Outcome for Stage II/III Gastric Cancer

8. Data from A Four-Factor Immunoscore System That Predicts Clinical Outcome for Stage II/III Gastric Cancer

9. Data from BI1071, a Novel Nur77 Modulator, Induces Apoptosis of Cancer Cells by Activating the Nur77-Bcl-2 Apoptotic Pathway

10. Data from BI1071, a Novel Nur77 Modulator, Induces Apoptosis of Cancer Cells by Activating the Nur77-Bcl-2 Apoptotic Pathway

11. Supplementary methods and Supplementary Figures S1-S8 from BI1071, a Novel Nur77 Modulator, Induces Apoptosis of Cancer Cells by Activating the Nur77-Bcl-2 Apoptotic Pathway

12. Supplementary Figures 1-5 from Dual EGFR/HER2 Inhibition Sensitizes Prostate Cancer Cells to Androgen Withdrawal by Suppressing ErbB3

13. Supplementary Figures 1-5 from Dual EGFR/HER2 Inhibition Sensitizes Prostate Cancer Cells to Androgen Withdrawal by Suppressing ErbB3

14. Supplementary Figures S1-S6 from Nitrostyrene Derivatives Act as RXRα Ligands to Inhibit TNFα Activation of NF-κB

15. Supplementary Table S1 from Nitrostyrene Derivatives Act as RXRα Ligands to Inhibit TNFα Activation of NF-κB

16. Data from Nitrostyrene Derivatives Act as RXRα Ligands to Inhibit TNFα Activation of NF-κB

17. Data from Nitrostyrene Derivatives Act as RXRα Ligands to Inhibit TNFα Activation of NF-κB

18. Supplementary Table S2 from Nitrostyrene Derivatives Act as RXRα Ligands to Inhibit TNFα Activation of NF-κB

19. Supplementary Table S3 from Nitrostyrene Derivatives Act as RXRα Ligands to Inhibit TNFα Activation of NF-κB

20. Supplementary Table 1, Figures 1-4, Methods from Nrdp1-Mediated Regulation of ErbB3 Expression by the Androgen Receptor in Androgen-Dependent but not Castrate-Resistant Prostate Cancer Cells

21. Supplementary Methods from Nitrostyrene Derivatives Act as RXRα Ligands to Inhibit TNFα Activation of NF-κB

22. Supplementary Figure Legend from Nitrostyrene Derivatives Act as RXRα Ligands to Inhibit TNFα Activation of NF-κB

23. Supplementary Methods from Nitrostyrene Derivatives Act as RXRα Ligands to Inhibit TNFα Activation of NF-κB

24. Supplementary Table 1, Figures 1-4, Methods from Nrdp1-Mediated Regulation of ErbB3 Expression by the Androgen Receptor in Androgen-Dependent but not Castrate-Resistant Prostate Cancer Cells

25. Data from Nrdp1-Mediated Regulation of ErbB3 Expression by the Androgen Receptor in Androgen-Dependent but not Castrate-Resistant Prostate Cancer Cells

26. Supplementary Table S3 from Nitrostyrene Derivatives Act as RXRα Ligands to Inhibit TNFα Activation of NF-κB

27. Supplementary Table S2 from Nitrostyrene Derivatives Act as RXRα Ligands to Inhibit TNFα Activation of NF-κB

28. Supplementary Table S1 from Nitrostyrene Derivatives Act as RXRα Ligands to Inhibit TNFα Activation of NF-κB

29. Supplementary Figures S1-S6 from Nitrostyrene Derivatives Act as RXRα Ligands to Inhibit TNFα Activation of NF-κB

30. Supplementary Figure Legend from Nitrostyrene Derivatives Act as RXRα Ligands to Inhibit TNFα Activation of NF-κB

32. BI1071, a Novel Nur77 Modulator, Induces Apoptosis of Cancer Cells by Activating the Nur77-Bcl-2 Apoptotic Pathway

33. A Four-Factor Immunoscore System That Predicts Clinical Outcome for Stage II/III Gastric Cancer

34. Nitrostyrene Derivatives Act as RXRα Ligands to Inhibit TNFα Activation of NF-κB

35. Abstract 3578: Androgen receptor transcriptionally targets the ErbB3 regulator Nrdp1 in the presence of nuclear Filamin A.

37. Abstract A12: Identification of Nrdp1 as a novel androgen receptor transcription target differentially regulated in androgen-dependent and independent prostate cancer

38. Dual EGFR/HER2 Inhibition Sensitizes Prostate Cancer Cells to Androgen Withdrawal by Suppressing ErbB3

39. Nrdp1-Mediated Regulation of ErbB3 Expression by the Androgen Receptor in Androgen-Dependent but not Castrate-Resistant Prostate Cancer Cells

Catalog

Books, media, physical & digital resources